Skip to main content
Top
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Research

Malnutrition, a new inducer for arterial calcification in hemodialysis patients?

Authors: Kun Zhang, Gang Cheng, Xue Cai, Jie Chen, Ying Jiang, Tong Wang, Jingfeng Wang, Hui Huang

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Background

Arterial calcification is a significant cardiovascular risk factor in hemodialysis patients. A series of factors are involved in the process of arterial calcification; however, the relationship between malnutrition and arterial calcification is still unclear.

Methods

68 hemodialysis patients were enrolled in this study. Nutrition status was evaluated using modified quantitative subjective global assessment (MQSGA). Related serum biochemical parameters were measured. And the radial artery samples were collected during the arteriovenous fistula surgeries. Hematoxylin/eosin stain was used to observe the arterial structures while Alizarin red stain to observe calcified depositions and classify calcified degree. The expressions of bone morphogenetic protein 2 (BMP2) and matrix Gla protein (MGP) were detected by immunohistochemistry and western blot methods.

Results

66.18% hemodialysis patients were malnutrition. In hemodialysis patients, the calcified depositions were mainly located in the medial layer of the radial arteries and the expressions of BMP2 and MGP were both increased in the calcified areas. The levels of serum albumin were negatively associated with calcification score and the expressions of BMP2 and MGP. While MQSGA score, serum phosphorus and calcium × phosphorus product showed positive relationships with calcification score and the expressions of BMP2 and MGP.

Conclusions

Malnutrition is prevalent in hemodialysis patients and is associated with arterial calcification and the expressions of BMP2 and MGP in calcified radial arteries. Malnutrition may be a new inducer candidate for arterial calcification in hemodialysis patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002, 62: 245-252.CrossRefPubMed Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002, 62: 245-252.CrossRefPubMed
2.
go back to reference London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003, 18: 1731-1740.CrossRefPubMed London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003, 18: 1731-1740.CrossRefPubMed
3.
go back to reference Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001, 38: 938-942.CrossRefPubMed Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001, 38: 938-942.CrossRefPubMed
4.
go back to reference Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005, 68: 429-436.CrossRefPubMed Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005, 68: 429-436.CrossRefPubMed
5.
go back to reference Zebboudj AF, Imura M, Bostrom K: Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem. 2002, 277: 4388-4394.CrossRefPubMed Zebboudj AF, Imura M, Bostrom K: Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem. 2002, 277: 4388-4394.CrossRefPubMed
6.
go back to reference Li X, Yang HY, Giachelli CM: BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 2008, 199: 271-277.PubMedCentralCrossRefPubMed Li X, Yang HY, Giachelli CM: BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 2008, 199: 271-277.PubMedCentralCrossRefPubMed
7.
go back to reference Luo G, Ducy P: Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature. 1997, 388: 78-81.CrossRef Luo G, Ducy P: Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature. 1997, 388: 78-81.CrossRef
8.
go back to reference Kopple JD: Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J. 1997, 43: 246-250.PubMed Kopple JD: Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J. 1997, 43: 246-250.PubMed
9.
go back to reference Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC: A modified quantitative subjective global assessment of nutrition for dialysis patients. Kidney Int. 1999, 14: 1732-1738. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC: A modified quantitative subjective global assessment of nutrition for dialysis patients. Kidney Int. 1999, 14: 1732-1738.
10.
go back to reference Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002, 61: 638-647.CrossRefPubMed Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002, 61: 638-647.CrossRefPubMed
11.
12.
go back to reference Goodman WG: Vascular calcification in end-stage renal disease. J Nephro. 2002, 15 (Suppl 6): S82-S85. Goodman WG: Vascular calcification in end-stage renal disease. J Nephro. 2002, 15 (Suppl 6): S82-S85.
13.
go back to reference Mehrotra R, Kopple JD: Nutritional management of maintenance dialysis patients: why aren’t we doing better?. Annu Rev Nutr. 2001, 21: 343-379.CrossRefPubMed Mehrotra R, Kopple JD: Nutritional management of maintenance dialysis patients: why aren’t we doing better?. Annu Rev Nutr. 2001, 21: 343-379.CrossRefPubMed
14.
go back to reference Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis. 2009, 53: 298-309.CrossRefPubMed Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis. 2009, 53: 298-309.CrossRefPubMed
15.
go back to reference Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006, 47: 139-148.CrossRefPubMed Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006, 47: 139-148.CrossRefPubMed
16.
go back to reference Ketteler M, Rothe H, Kruger T, Biggar PH, Schlieper G: Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nat Rev Nephrol. 2011, 7: 509-516.PubMed Ketteler M, Rothe H, Kruger T, Biggar PH, Schlieper G: Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nat Rev Nephrol. 2011, 7: 509-516.PubMed
17.
go back to reference Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008, 73: 391-398.CrossRefPubMed Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008, 73: 391-398.CrossRefPubMed
18.
go back to reference Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, Kalantar-Zadeh K: Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011, 58: 418-428.PubMedCentralCrossRefPubMed Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, Kalantar-Zadeh K: Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011, 58: 418-428.PubMedCentralCrossRefPubMed
19.
go back to reference Nakagawa Y, Ikeda K, Akakabe Y, Koide M, Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H: Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol. 2010, 30: 1908-1915.CrossRefPubMed Nakagawa Y, Ikeda K, Akakabe Y, Koide M, Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H: Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol. 2010, 30: 1908-1915.CrossRefPubMed
20.
21.
go back to reference Proudfoot D, Shanahan CM: Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein. Nephrology. 2006, 11: 455-461.CrossRefPubMed Proudfoot D, Shanahan CM: Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein. Nephrology. 2006, 11: 455-461.CrossRefPubMed
22.
go back to reference Zebboudj AF, Shin V, Bostrom K: Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem. 2003, 90: 756-765.CrossRefPubMed Zebboudj AF, Shin V, Bostrom K: Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem. 2003, 90: 756-765.CrossRefPubMed
Metadata
Title
Malnutrition, a new inducer for arterial calcification in hemodialysis patients?
Authors
Kun Zhang
Gang Cheng
Xue Cai
Jie Chen
Ying Jiang
Tong Wang
Jingfeng Wang
Hui Huang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-66

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.